CME Group (CME)
Coverage summary
Aardvark Labs Capital Research has covered CME Group (CME) since July 24, 2025. The company is in the Financial Services sector. This page lists 5 reports: 5 earnings recaps.
The latest is the Q2 2026 Earnings Recap, published July 22, 2026. The current rating is Outperform, unchanged since the Q1 2026 Earnings Recap of April 23, 2026. The rating has changed once since coverage began.
Translations: 5 in Chinese.
Rating history
All CME reports
Recap: Q2 2026
The Step-Up Holds Against Its Hardest Comp, and the Perpetuals Panic Looks Like a Gift
Recap: Q1 2026
A Record 36.2 Million-Contract Quarter Across All Six Asset Classes, and a Stock That Shrugged
Recap: Q4 2025
A Fourth Straight Record Year and the Highest Q4 Volume Ever, but the Stock Sits at an All-Time High Into a 2026 Cost Step-Up
Recap: Q3 2025
Volumes Give Back the Record, but a Firmer Rate Per Contract, Record Market Data and Cost Discipline Hold EPS Flat
Recap: Q2 2025
The First 30 Million-Contract Quarter Sets Records Across the Board, but a Flat Tape and a Full Multiple Argue for Patience